Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

FDA Committee Recommends Combined DTP, Haemophilus influenzae Vaccine

FDA Committee Recommends Combined DTP, Haemophilus influenzae Vaccine A SIMPLIFIED PEDIATRIC immunization schedule appears about ready to become a reality. The Food and Drug Administration (FDA), Rockville, Md, has been advised by one of its review committees to license a combined diphtheria-tetanus-(whole-cell) pertussis vaccine linked with a Haemophilus influenzae type b conjugate vaccine. The result would be to reduce by half the number of injections that infants and children receive to be immunized against these diseases. David McLintock, PhD, Lederle-Praxis Laboratories, a division of American Cyanamid Co, Wayne, NJ, says: "The two vaccines overlap in their use, being given at 2, 4, and 6 months of age with a booster at 15 to 18 months. So it was natural to combine them into a single ready-to-use vaccine." Advisory Committee Meeting McLintock spoke at a meeting of the advisory committee on vaccines and related biological products of the FDA's Center for Biologics and Evaluation and Research. Although there was http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

FDA Committee Recommends Combined DTP, Haemophilus influenzae Vaccine

Marwick, Charles
JAMA , Volume 268 (24) – Dec 23, 1992
Download PDF
1 page

FDA Committee Recommends Combined DTP, Haemophilus influenzae Vaccine

Abstract


A SIMPLIFIED PEDIATRIC immunization schedule appears about ready to become a reality.
The Food and Drug Administration (FDA), Rockville, Md, has been advised by one of its review committees to license a combined diphtheria-tetanus-(whole-cell) pertussis vaccine linked with a Haemophilus influenzae type b conjugate vaccine. The result would be to reduce by half the number of injections that infants and children receive to be immunized against these diseases.
David McLintock, PhD,...
Loading next page...
 
/lp/american-medical-association/fda-committee-recommends-combined-dtp-haemophilus-influenzae-vaccine-UrxuvDFf8V

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
American Medical Association
Copyright
Copyright © 1992 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.1992.03490240015004
Publisher site
See Article on Publisher Site

Abstract

A SIMPLIFIED PEDIATRIC immunization schedule appears about ready to become a reality. The Food and Drug Administration (FDA), Rockville, Md, has been advised by one of its review committees to license a combined diphtheria-tetanus-(whole-cell) pertussis vaccine linked with a Haemophilus influenzae type b conjugate vaccine. The result would be to reduce by half the number of injections that infants and children receive to be immunized against these diseases. David McLintock, PhD, Lederle-Praxis Laboratories, a division of American Cyanamid Co, Wayne, NJ, says: "The two vaccines overlap in their use, being given at 2, 4, and 6 months of age with a booster at 15 to 18 months. So it was natural to combine them into a single ready-to-use vaccine." Advisory Committee Meeting McLintock spoke at a meeting of the advisory committee on vaccines and related biological products of the FDA's Center for Biologics and Evaluation and Research. Although there was

Journal

JAMA – American Medical Association

Published: Dec 23, 1992

There are no references for this article.